These shallow injections are generally easy to administer and involve minimal discomfort
- Suppress appetite - Slow gastric emptying (food stays in the stomach longer) - Increase feelings of fullness - Reduce calorie intake, often dramatically - Fast initial weight loss - Reduced cravings - Easier adherence to a calorie deficit in the short term From a purely scale-based perspective, GLP-1 medications can appear very effective
GLP-1, GIP, and glucagon receptors agonist Triple receptor agonists activating GLP-1, GIP, and glucagon receptors have recently been developed
Semaglutide is an injectable glucagon-like peptide GLP 1 analogue used to treat type 2 diabetes and is now approved under the brand name Wegovy for chronic weight management in individuals with a BMI of 27 or higher
The Adaptation Index, a marker of -cell function, increased from 5.16 10 4 3,833.80 a.u